Sign Up
Stories
Advancements in Medical Trials
Share
Advancements in Antibodies to Protect Im...
Advancements in Cancer Treatment and Mar...
Advancements in Medical Research
Broccoli Compound Enhances Stroke Treatm...
MetrioPharm's MP1032 Shows Promising Res...
Promising Trials for Post-COVID-19 and G...
Overview
API
Incyte and Syndax present positive data from AGAVE-201 clinical trial for axatilimab in chronic GvHD, while GeNeuro's trial evaluating temelimab for post-COVID-19 symptoms continues without modifications.
Ask a question
How do these advancements in medical trials reflect the ongoing efforts to develop effective treatments for chronic conditions?
How might the positive data from the AGAVE-201 trial impact the future treatment options for chronic GvHD patients?
What are the potential implications of GeNeuro's trial results on the understanding and treatment of post-COVID-19 symptoms?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Dec 2023
Coverage